Hans Jörg Reinhardt is a German businessperson who has been at the head of 9 different companies. Presently, he occupies the position of Chairman for Institute of Molecular & Clinical Ophthalmology Basel and Independent Non-Executive Chairman for Novartis AG, Chairman-Supervisory Board for Novartis International AG, Chairman for Novartis Institutes for Biomedical Research, Inc., Chairman-Supervisory Board for Novartis Pharma AG and Chairman of Novartis, Inc. (which are all subsidiaries of Novartis AG). Hans Jörg Reinhardt is also on the board of Novartis Institute for Functional Genomics, Inc. and Swiss Re AG and Chairman of Novartis Foundation and Council Member at International Federation of Pharmaceutical Manufacturers.
Dr. Reinhardt previously held the position of Chairman at Genomics Institute of The Novartis Research Foundation, Chief Operating Officer for Novartis AG and Head-Development at Sandoz Pharmaceuticals AG (a subsidiary of Novartis AG) and Chairman-Management Board at Bayer HealthCare AG.
Hans Jörg Reinhardt received a doctorate from Universität des Saarlandes.